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Part 1: Original Paper

African American Parents’
HPV Vaccination Intent and Concerns
Vetta L. Sanders Thompson, PhD, MA
Lauren D. Arnold, PhD, MPH
Sheri R. Notaro, PhD, MPH
Abstract: This study describes attitudes and social and environmental factors that affect
African American parents’ intent to vaccinate their daughters against human papillomavirus
(HPV). Thirty African American parents of daughters aged nine to 17 years and no history of HPV infection completed semi-structured interviews. Interviews addressed factors
that influenced intent to vaccinate, perception of community norms related to vaccination,
vaccination scenarios involving place of vaccination, and vaccination prior to or after the
child’s initiation of sexual activity. A recurring theme was the influence of physician recommendation on African American parents’ intent to obtain HPV vaccination for their
daughters. Most parents reported that they could overcome barriers to vaccination, except
vaccine costs and lack of insurance. While religious beliefs were important to parents, they
reported that they would not interfere with vaccination decisions; fears of early sexuality
due to vaccination were limited. The implications of these findings are discussed.
Key words: African Americans, HPV vaccination, cultural attitudes and beliefs.

A

frican American women experience higher cervical cancer incidence and mortality
than their non-Hispanic White counterparts.1–3 The prevalence of human papillomavirus (HPV) infection, which is associated with cervical cancer, is significantly
higher in African American women as well.4 Although HPV vaccination can substantially
lower the risk of cervical cancer, data indicate that less than 20% of eligible girls are fully
vaccinated.5 Being African American has been correlated with both lower initiation and
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lower completion of the HPV vaccine series.6,7 Given the higher cervical cancer burden
in African Americans, understanding factors that affect HPV vaccination behaviors,
including parental attitudes towards HPV vaccination of their daughters, is critical.
Given that HPV vaccination is targeted at preadolescents or young adolescents, vaccine acceptability to parents is a central issue, and it is important to understand parental
concerns and information needs. Studies also suggest that parental attitudes influence
adolescent attitudes related to intent to receive the HPV vaccine.8–10 Constantine and
Jerman completed a random digit dial household survey of parental intent to vaccinate
in California.11 Data from this survey indicated that African American and Asian parents were less likely than others to accept HPV vaccination.11 However, the number of
African American participants was limited (n=36), which weakens confidence in the
findings. Other studies have indicated greater skepticism among African American
and Hispanic parents than among others.12,14,15 Many parents do not understand the
rationale for the vaccine’s target age range and the implications of a vaccination decision
for their children at any age.11–15 In addition, some parents have expressed concerns
related to vaccine use and risky sexual behavior among adolescents, as well as mistrust
of pharmaceutical companies promoting HPV vaccine use.11 While there are other
studies of barriers to HPV vaccine use,16–18 results often are not reported separately for
African Americans or other racial/ethnic minorities included in the samples. Finally,
the studies that do report on African American parental concerns were conducted in
Western or Southern states. Geographic variation in vaccination suggests a need to
understand whether there are regional variations in parental attitudes that may affect
HPV intent to vaccinate.19
To address disparities in cancer incidence and mortality in an urban, Midwestern
city, researchers from a Community Networks Program to Eliminate Cancer Disparities (PeCAD) conducted surveys and interviews to assess cervical cancer, HPV, and
Pap smear knowledge among African American parents of females in the vaccination
age range, as well as beliefs, attitudes, and structural barriers to HPV vaccination. An
analysis of the interview data is presented in this paper. The primary aims of this project
were to describe the cultural attitudes and social and environmental factors that affect
African American parents’ intent to vaccinate. The use of individual interviews permits
consideration of how the expression of religious, sexual, and health-related values, in
addition to the influence of significant others, affect African American parents’ HPV
decision making. This understanding can be useful in the consideration of education
and intervention efforts.

Methods
Participants. Study recruitment took place between February and June of 2009. Data
presented here include the qualitative portion of a larger study of African American
parents’ attitudes toward HPV vaccination. The parent study involved 200 African
American men and women who completed a survey study, with a subset of 30 participants selected for interview. The detailed methods used in the survey portion of
the study are described in a separate paper.20 All participants were residents of the St.
Louis Metropolitan Statistical Area. Eligibility criteria for the survey and the interview
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were men and women who: 1) identified as African American, and 2) had a daughter
nine to 17 years of age with no history of HPV infection.
Procedures. The Washington University in St. Louis’ Institutional Review Board
approved this study and consent procedures. We used several sampling strategies. Community organizations, including a reproductive health service, father support center,
and two health centers were primary recruitment sites. Each African American patron
present during operational hours was approached to determine eligibility. This strategy
resulted in 21 completed interviews. In addition, a community sampling strategy21 was
used to diversify the sample and recruit individuals who did not participate in established
organizations or seek health care from a usual source. Homes in ZIP codes containing
more than 75% African Americans were approached to solicit eligible participants. Nine
interview participants were recruited using this sampling strategy.
Participants were approached by the African American principal investigator or one
of two African American research assistants to complete a self-administered survey and
received a $25.00 gift card for participation. The person soliciting survey participation
also requested interview participation. Every third participant who received an odd
identification number was asked to complete an interview, which took between 45 and
60 minutes, until 30 participants (15% of the total sample) were interviewed. Refusal
data were not recorded. Interviews were scheduled at participants’ convenience and
completed at their preferred location. The majority of interviews were completed in
participants’ homes (n19), with five completed in a private interview room at the
recruitment site and six completed in an interview room at the investigator’s university.
All participants received a detailed explanation of the interview before providing
consent and received an additional payment of $30. Interviews were audio-taped and
transcribed verbatim. The transcripts were reviewed for accuracy by a research assistant,
using the audiotape and field notes.
Interview protocol. Interview questions were developed by the first author based on
a review of the existing literature and surveys found in the literature.16,22,23 The protocol
used a problem-centered interview format, with a focus on HPV, HPV vaccine knowledge, intent, and behavior, as well as facilitators and barriers to vaccination. Participants
were asked to discuss their intent to have eligible children receive the vaccine, factors
that influence intent or the decision to vaccinate (if a child received the vaccine), and
their perception of community norms and concerns related to vaccination. Additionally, they were asked to respond to materials that presented HPV vaccination in the
context of sexual health vs. cancer prevention, vaccination scenarios involving location of vaccination (private physician, community health clinic, health department,
or facilities providing reproductive health services), and vaccination prior to or after
the child’s initiation of sexual activity. Interviewers listened for themes and followed
up on topics relevant to issues raised in prior interviews. Interviewers maintained the
protocol, which provided prompts to permit interviewers to guide participants back
to the central issue being explored, obtain greater details on topics raised, and obtain
elaborations of ideas that seemed important. Field notes developed after each interview
described the setting and any notable participant observations.24,25
Data analysis. The research team consisted of a psychologist and two graduate
research assistants, who developed initial rules and categories for coding after review-
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ing project goals, the content of the interviews, and the existing literature. The coding
scheme was revised as coding proceeded to include omitted categories and assure that
interview content was accurately represented. There were three statement types coded:
anecdotes, general attitudes or beliefs, and statements specific to HPV. The HPV-specific
codes focused on positive or negative intent to vaccinate, attitudes related to vaccination
encountered among physicians, family members, friends, and/or faith-based community
members, statements specific to religious attitudes, youth sexuality, vaccine knowledge
needs and safety, and barriers to vaccination. Additional coding captured statements
related to preferences for receiving vaccine information and administration.
Each interview was coded by two people. Each coder read and coded assigned transcripts and then met with the partner to review codes and discuss any discrepancies
until reaching consensus.24 Because coding was iterative, many discrepancies in early
coding were related to the addition of new codes or to the elaboration of existing codes.
The consensus approach was used to resolve these issues and the coding of earlier text
was revised to reflect the new coding. If coders did not reach consensus, the principle
investigator made the final coding decision based on a reading of the transcript text,
review of coding rules, and available survey data. Once coding was complete, all three
team members met to discuss core ideas and general themes. The discussions yielded
a set of attitudes about HPV vaccination intent and the factors that influenced parents’
decisions, including community norms, HPV vaccination concerns, the role of beliefs
about youth sexuality, and the role of religion and other barriers related to intent to
vaccinate. These core findings were then refined and prioritized. The project’s community advisory council reviewed and provided comments on these findings.

Results
Interview participants included 25 women and five men, with an average age of 42.4
years (range: 26–60). All interview participants reported that there was a usual place
where they took a child for, or a usual person who provided, sick or routine care (e.g.,
private physician, federally qualified and community health clinics). Sixteen participants
reported the use of private health insurance for their children, and another 10 parents
reported that their daughters had some form of health insurance identified as Medicaid
or State Children’s Health Insurance Program (SCHIP). Four parents indicated that
they and their children were uninsured. The participant interviews offer insights into
the factors that influence parental decisions about HPV vaccination. Six major themes
were identified: the influence of physician recommendation, vaccine decision-making,
desire for information related to vaccine safety, youth sexuality, HPV vaccine costs,
and religious issues affecting HPV vaccination decisions.
Physician recommendation. Physician recommendation was important in the
decision to vaccinate due to interpersonal and professional factors. Most patients cited
their trust of and long-term relationships with their child’s provider. In addition, several
parents noted the importance of medical history in the decision to vaccinate and the
ability of the physician to weigh the family and child’s health history when making a
recommendation on HPV vaccination.
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Parent (P): Just because that’s who does all of her medical treatment. They know her
medical history. They know her. So, I feel better with them providing her with any
vaccinations or anything that she gets.
P: Well, like I say, he’s been there since my kids been born. Plus he was my brother’s
pediatrician. He’s [the brother], like 26 years old. He’s a family doctor you know. He’s
been going down the line. So I really do trust him.

Parents gave examples of the rationales that physicians offered for their recommendations, which included a history of chronic diseases such as sickle cell anemia and
asthma. These parents indicated that the decision to vaccinate was to protect against
infections that these chronically ill children would find more difficult to fight. Additionally, the child’s sexual activity or lack of sexual activity and vaccine safety were
reportedly rationales for physician recommendation to vaccinate.
P: Well, when she went for her physical, her pediatrician said that she wanted to wait
for her to get the vaccination, because, I guess, the drug, or something with the vaccination hasn’t been FDA approved for at least five years. So she didn’t recommend
her to get it just yet.

Participants in this sample were less concerned about their own knowledge because
they felt that they could discuss these issues and obtain the necessary information from
their providers. While parents noted that they lacked knowledge and were unlikely to
vaccinate in the absence of a physician recommendation, there were limits on the role
of the physician in the final decision to obtain HPV vaccination for their daughters.
Parents went on to indicate that the final decision about vaccination was theirs.
P: Her doctor was really pushing getting the vaccination. But I had to read up on it,
get more information than I previously had. I try to impress upon my children the
importance of being proactive about your own health.

Vaccine decision-making. Men and women agreed that the final decision about
HPV vaccination for their daughter’s was most often made by mothers, with father
consultation as the mother thought necessary.
P: I mean, because, you know, my husband leaves it up to me. My children, you know,
it’s just I’ve always handled things.

Most parents felt that the child could express feelings and concerns about vaccination,
but ultimately the decision was made by the parent(s).
P: She and her mother would discuss it and we’d [father and mother] just make a
decision for her.
P: Because at a certain age you do not be a part of decisions. I’d say when you at least
18; you can decide.
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Many reported that they felt obligated to inform their daughters about HPV, the vaccine and why they believed the vaccine was or was not beneficial.
P: She was involved at the last minute. I gave her the pamphlet to read and talked to
her you know. But other than that, no, I didn’t go into detail or anything.
P: I would give her some information about it. Letting her know why she would have
to take it. I: “What if she didn’t want to take it?” P: I would find out why she wouldn’t
take it. We would discuss the pros and cons to help her make an informed decision.

Parents questioned the appropriateness of mandatory vaccination because of the
likelihood of interfering with the parent’s decision making role, perceived differences
in children’s risk of exposure to HPV, and possible religious objections.
P: No I can’t say that I agree with that because I have a sister-in-law that Jehovah’s
Witnesses and they don’t believe in a whole lot of stuff, so that they shouldn’t force
it on people.
P: Because if you feel that something is good for my child, that’s not really right [to
make it mandatory]; because some vaccinations, I just feel it might not be necessary.

Vaccine safety. In response to queries about barriers to vaccination, side-effects
were most often cited. Many parents noted that they had seen very little information
on the side-effects of youth HPV vaccination.
P: Well, when I first heard about it, I said, Okay. But, what about the side effects?
Because we haven’t really heard anything about the side effects.

When asked what side-effects would be of concern, they noted death, infertility, or risk
of other diseases such as autism. Participants indicated that they were not concerned
about side-effects such as dizziness, nausea, pain and swelling at the injection site, or
fainting.
P: No, those [dizziness, nausea, pain and swelling at the injection site, or fainting]
could be like remedied. Because sometimes, while a young girl menstrual, she’ll
experience stuff like that. So that’s minor, minor. Bigger issues are, you know, how
it will affect her mentally and physically and, you know, skin irritation [skin breaks
out in blotches] and you know, if she had swelling of the limbs and things like that.
P: If there is a 50/50 chance that it [HPV] would leave my child handicapped or
something, that would turn me off.
P: Probably anything that would adversely affect her female organs, her reproductive
organs, you know, or would cause damage to her like immune system or something
like that.
P: My concern was would it make her menstruation act crazy, would she gain weight
or change her eating habits, you know, would it affect her physical health. That was
my concern.
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One parent was very knowledgeable about the vaccine and discussed HPV vaccine
safety in terms of a false sense of safety. She noted that the HPV vaccine did not protect
against all strains of the virus and might lead youth to forget the health risks associated
with strains that were not protected against.
Males were more likely to express concerns about the government’s role in the development of the HPV vaccine and vaccination efforts and their implications for HPV
vaccine safety. Several men made comments such as, “Tuskegee has to be considered.”
Female participants expressed varied views, from dismissal of concerns related to
experimentation to the importance of participating in vaccine and other research in
order to improve community health.
P: No, they experiment on everybody. I mean, how do they think, the people will have
to experiment to know what’s good. I mean, they experiment on animals. Animals is
animals, humans is humans, okay, so if they experiment on people that’s your decision if you want them to experiment and for you to get help. I mean, they tell you
when you get it, it’s a risk.
P: They experiment on everybody with it though. It’s not necessarily just Black people.

Youth sexuality. Parents noted that they would see more urgency to HPV vaccination if they believed that their daughters were sexually active; however, sexuality was
not the primary basis for making the HPV decision. Parents reported that the health
of the child was the main factor in their HPV vaccination decision.
P: I explained to my daughter, it’s not about trying to have sex or be grown. It’s about
your health, what’s important for you. It’s about cancer.

Parents also commented that they did not believe that HPV vaccination would encourage
early sexuality. One parent stated, “The shot [is] not a hormone shot; it will not make
them want to have sex.” Parents did discuss that adolescents might not understand
that they were only being protected against cervical cancer. This lack of understanding
was discussed in relationship to sexual risk taking among vaccinated youth. However,
parents indicated that youth engaging in risky sexual behavior were likely to do so
regardless of HPV vaccination status, and that this was an issue of parent child communication and supervision.
P: Getting them the vaccination, no, that’s not a sign. Now putting them on birth
control, that’s a sign of permission.
P: I guide them, even my son. You know, I talk about abstinence all the time. So guide
them. After they graduate and get out of my household, that’s fine. But while they’re
here, no. I know they’re young, and I know they’re human and things come up. But,
I don’t think it really give them permission to have sex.

The age of the child was discussed as a part of concerns about sexuality. Parents expressed
reluctance to vaccinate girls as young as nine years old. Parents stated that they were less
concerned about sexuality at this age, which was believed to inform risk of infection.
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Parents reported that they had time to protect their daughter’s health. Most expressed
a preference that HPV vaccination not be discussed before age 12.
Vaccine costs. When costs and religious issues were not discussed, participants were
queried about these issues. Parents indicated that private insurance or Medicaid coverage
made vaccination feasible given the cost of the series of shots. Among those parents
who were unaware that HPV vaccination involved three shots, costs were not viewed
as a barrier. Among parents who were unaware of the HPV vaccine associated costs,
the researchers provided this information to gain insight into how this knowledge of
HPV vaccine related costs would affect their attitudes about HPV vaccination. Many
parents were shocked at the costs and this led to more extensive discussions of this
issue. Those with insurance were less concerned, but indicated that coverage by their
insurer would determine whether the vaccination was provided. Uninsured parents
expressed caution toward HPV vaccine uptake. They discussed the need to ensure that
they would not incur medical bills that they were unable to pay.
P: It’s only going to affect my decision to a point; if it’s something that I deem necessary or we (husband) deem necessary, then it’s going to happen.
P: I mean as long as it’s within reason and it’s something that I feel I could pay for and
afford, then no cost would not affect my decision. If it’s not like an outrageous price.

HPV vaccine and religious issues. Religious concerns were discussed when the
researchers asked about them, but participants did not believe that the issue affected
their decisions about their own child(ren). Participants who expressed a devout commitment to their religious beliefs stated that they would pray for guidance, but many
indicated that church leaders and doctrine could not decide the issue of HPV vaccination.
P: Yeah, yes, I did. I always trust God first. I always pray for guidance and protection.
And if it’s something He put on this earth to help His people, then yes, you know, I
want that to be given to my daughter. I’m led by the Holy Spirit. It led me to make
the right decision that this would help her, you know, then yeah.

One participant noted the importance of a “spirit of discernment,” in which religious
beliefs, prayer and spiritual guidance are used to make individual decisions.
P: God has his place because—and that is at the head, but there are certain decisions,
you know he gives you the spirit of discernment too. So there are decisions that you
are gonna have to make whether he is involved in it or not.

Participants speculated that parents from some religious denominations, such as Jehovah’s Witness, might have stronger objections. There was also discussion of whether
older members of the church could be relied upon for advice and guidance as new
health issues and treatments emerged because of their tie to old-fashioned beliefs.
P: I could talk to my mother about it, but that would not go into my decision making process. Not that I don’t trust my mother’s opinion, but she knows less than I
do about it.
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Discussion
This paper adds to the literature on African American HPV vaccination attitudes and
presents data using a sample from the U.S. Midwest. African American parental interviews suggest confidence in the ability to obtain HPV vaccination for their age eligible
daughters. Although parents in this sample expressed confidence, they admitted that
they sometimes lacked necessary HPV knowledge and often relied on their physicians
for information to fill this knowledge gap. While many participants were religious,
religion did not appear to be a barrier to HPV vaccination and these parents dismissed
concerns that HPV vaccination would result in early or promiscuous sex. There were
however concerns about and a desire for information related to HPV vaccine safety
and costs, as well as age of vaccination.
Consistent with the literature,8–10 the strong role that physician recommendation plays
in African American parents’ intention to obtain HPV vaccination for their daughters
was noted. Parental discussions of HPV decision-making for their daughters suggest
that physician recommendations are likely to be followed in the context of an established
patient-provider relationship. Physicians were also seen as a source of information in
the absence of knowledge. As other researchers have noted,11,15 there were a number
of concerns related to vaccine safety, but these did not generally seem to be reflective
of medical mistrust. Parents noted that they had not heard or found much information on serious side effects (changes in menstruation, reproductive ability, or overall
health) from the vaccine. It appears that serious side effects would affect HPV vaccination intent more than more immediate side effects (pain, swelling at vaccination site,
fainting) most often described. Fathers expressed some mistrust of the vaccine based
on the government’s role in its development, but deferred decisions about vaccination
to mothers, most of whom rejected these concerns.
Contrary to previous findings,13,16 parents in this sample did not express concerns
that HPV vaccination would lead to early or increased youth sexuality. There were
concerns about vaccinating very young girls because they were perceived as less likely
to be sexually active. This view suggests that parents are not aware of the reasons for
the targeted ages for HPV vaccination, which is consistent with the findings of previous studies.11–15 This suggests an opportunity for education; parents should be helped
to understand that the goal is to vaccinate girls before they become sexually active in
order to increase the likelihood of vaccine efficacy. The attitudes related to religion and
religious beliefs were also somewhat different from those of previous studies.13,16 While
religion and religious attitudes were important to parents in this sample, they would
not interfere with decisions made about their children’s health. Parents were confident
in their ability to use prayer and personal guidance from God to make health decisions and expressed less reliance on church leadership. Parents reported an awareness
of sexual attitudes and beliefs within the community, church, and family that would
suggest negatives attitudes toward HPV vaccination, but contrary to earlier studies,
these attitudes were not prevalent among parents in our sample.
Most parents interviewed reported that they could overcome barriers to vaccination,
which have previously been associated with low vaccination rates. However, consistent
with previous studies,10 parents indicated that insurance coverage and reasonable costs
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were factors that they had to consider. Parental concerns related to costs suggest an
opportunity for education. The costs for the vaccine and lack of insurance should not
represent a barrier because HPV vaccination is covered under the Vaccine for Children program. If this information were readily available to uninsured parents it might
increase vaccination by allaying fears related to costs.
Implications. The addition of findings from a Midwest sample to the literature may
provide information that can inform educational campaigns to assist African American
parents to make informed decisions about HPV vaccination. New educational materials will be most useful to African American parents if they discuss both short and
long-term side effects of HPV vaccination, while also examining their seriousness.
Health promotion and education materials should include the most recent and accurate information on the side effect profile of the HPV vaccines now available. Parents
should also be informed of the Vaccine for Children program that can assist with the
costs of obtaining the HPV vaccination series. A new tool might also assist parents
by allowing them to weigh the side effects, benefits, costs, and any other individual,
social, or cultural concerns they might have to make the best decision for their child
and family circumstance. This suggests that some parents might find a decision tool
helpful. However, the most important activity will be working with the health care community to assure that African American parents and their age eligible children have an
opportunity to discuss sexual behavior and sexually transmitted infections, including
HPV, with their providers to facilitate informed decision-making and action, using
their preferred source of information and consultation. This focus on the health care
community should also include linking African American parents and their children
to health care resources. An emphasis should be placed on ensuring the establishment
of good patient-provider relationships so that the appropriate discussions take place.
Limitations. Researchers and health educators should carefully consider the limitations of these interviews when considering their utility in other settings and populations.
It is possible that the lack of diversity among survey administrators and interviewers
augmented the responses of study participants producing socially desirable comments.
Although an effort was made to include African Americans of diverse backgrounds, the
participants were not representative of a national or local sample of African Americans.
Therefore, there may be greater numbers of individuals with health care and physician
relationships in this sample, which may limit the generalizability of our findings. This
sample consisted of volunteers, and it is impossible to know how individuals who chose
to participate differ from those who did not; refusal rates and data on those refusing
were not collected. Finally, these interviews were completed before the approval of
Cervarix and before Gardasil was approved for men and only parents of girls were
interviewed and parental comments were focused on what they knew about Gardasil.
Conclusion. The findings of the current study suggest that African American
parents, in consultation with trusted health care providers, expect to exercise strong
influence over HPV vaccination of their daughters. While larger, long-term studies of
HPV vaccination attitude, intent, and behavior are needed, this study suggests HPV
and HPV vaccination information needs can be addressed through these health care
relationships and in targeted educational materials and decision tools.

African American parents and HPV vaccination

300

Acknowledgments
This research was funded by the National Cancer Institute at the National Institutes
of Health: Community Networks Program for the Elimination of Cancer Disparities,
Grant Numbers: 5-U01-CA114594, U54 CA153460; Center for Excellence in Cancer
Communication, IU48-DP-001903-01, and Grant Number UL1 RR024992: National
Center for Research Resources, a component of the National Institutes of Health and
NIH Roadmap for Medical Research. The second author owns Merck stock.

Notes
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.

National Cancer Institute. Surveillance epidemiology and end results. Bethesda, MD:
National Cancer Institute, 2007. Available at: http://seer.cancer.gov/statfacts/html
/cervix.html.
National Cancer Institute. State cancer profiles: death rates. Bethesda, MD: National
Cancer Institute, 2006. Available at: http://statecancerprofiles.cancer.gov/help/about
/descriptions.html#death_rates.
Kaiser Family Foundation. Missouri: women’s health status. Washington, DC: Kaiser
Family Foundation, 2007. Available at: http://www.statehealthfacts.org/profileind.jsp
?cat=10&sub=112&rgn=27.
Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females
in the United States. JAMA. 2007;297(8):813–9.
Nelson B. Lagging HPV vaccination rates dampen outlook in U.S.: cloudy prospects
for overcoming multiple barriers. Cancer Cytopathol. 2010 Jun;118(3):113–4.
Chao C, Velicer C, Slezak JM, et al. Correlates for human papillomavirus vaccination
of adolescent girls and young women in a managed care organization. Am J Epidemiol.
2010 Feb;171(3):357–67.
Chao C, Velicer C, Slezak JM, et al. Correlates for completion of 3-dose regimen of
HPV vaccine in female members of a managed care organization. Mayo Clin Proc.
2009 Oct;84(10):864–70.
Davis K, Dickman ED, Ferris D, et al. Human papillomavirus vaccine acceptability among parents of 10- to 15-year old adolescents. J Low Genit Tract Dis. 2004
Jul;8(3):188–94.
Zimet GD. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc
Health. 2005 Dec;37(6 Suppl):S17–23.
Reiter PL, Brewer NT, Gottlieb SL, et al. Parents’ health beliefs and HPV vaccination
of their adolescent daughters. Soc Sci Med. 2009 Aug;69(3):475–80.
Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among
Californian parents of daughters: a representative statewide analysis. J Adolesc Health.
2007 Feb;40(2):108–15.
Hughes J, Cates JR, Liddon N, et al. Disparities in how parents are learning about
the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev. 2009
Feb;18(2):363–72.
Allen JD, Othus MK, Shelton RC, et al. Parental decision making about the HPV
vaccine. Cancer Epidemiol Biomarkers Prev. 2010 Sep;19(9):2187–98.
Fazekas Kl, Brewer NT, Smith JS. HPV vaccine acceptability in a rural southern area.
J Womens Health (Larchmt). 2008 May;17(4):539–48.
Scarinci IC, Garces-Palacio IC, Partridge EE. An examination of acceptability of HPV

Thompson, Arnold, and Notaro

16.
17.
18.
19.
20.
21.
22.
23.
24.
25.

301

vaccination among African American women and Latina immigrants. J Womens
Health. 2007;16(8):1224–33.
Dempsey AF, Zimet GD, Davis RL, et al. Factors that are associated with parental
acceptance of human papillomavirus vaccines: a randomized intervention study of
written information about HPV. Pediatrics. 2006 May;117 (5):1486–93.
Sharpe PA, Brandt HM, McCree DH. Knowledge and beliefs about abnormal Pap test
results and HPV among women with high-risk HPV: results from in-depth interviews.
Women Health. 2005;42(2):107–33.
Sperber NR, Brewer NT, Smith JS. Influence of parent characteristics and disease
outcome framing on HPV vaccine acceptability among rural, Southern women.
Cancer Causes Control. 2008 Feb;19(1):115–8.
Centers for Disease Control and Prevention. National, state, and local area vaccination
coverage among adolescents aged 13–17 years—United States, 2008. MMWR Morb
Mortal Wkly Rep. 2009 Sep 18;58(36):997–1001.
Thompson VL, Arnold LD, Notaro SR. African American parents’ attitudes toward
HPV vaccination. Ethn Dis. 2011 Summer;21(3):335–41.
Thompson VL, Kalesan B, Wells A, et al. Comparing the use of evidence and culture
in targeted colorectal cancer communication for African Americans. Patient Educ
Couns. 2010 Dec;81(Suppl):S22–33.
Kahn JA, Ding L, Huang B, et al. Mothers’ intention for their daughters and themselves
to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics.
2009 Jun;123(6):1439–45.
Zuckerman M. Human sexuality questionnaire. In: Davis CM, Yarber WL, Bauserman R, et al., eds. Handbook of sexuality-related measure. Thousand Oaks, CA: Sage,
1998; 109–15.
Flick U. An introduction to qualitative research (2nd ed.). Thousand Oaks, CA: Sage,
2002.
Nichter M, Quintero G, Nichter, M, et al. Qualitative research: contributions to the
study of drug use, drug abuse, and drug use(r)-related interventions. Subst Use Misuse.
2004;39(10–12):1907–69.

